KIPI MALOY, Indonesia, March 08, 2018 -- Continental Energy Corporation (OTCQB:CPPXF) (the “Company”) today announced that its Indonesian subsidiary, PT Kilang Kaltim Continental ("KKC"), has awarded a contract to PT MIT IVEL Geoscience ("MIT") of Bandung, Indonesia, for the provision of services related to site geotechnical surveys for KKC's Maloy Refinery.
Under the contract, MIT will undertake site topographic mapping, soil testing, and similar geotechnical surveys within the KIPI Maloy Port and Industrial Park to facilitate KKC's selection of a suitable 30 to 45 hectare site for the erection of KKC's Maloy Refinery. Additionally, MIT will advise KKC and assist with the preparation of survey and analysis for suitable sites for refinery related tank storage and truck and marine distribution terminals.
About PT Kilang Kaltim Continental - KKC is the holder of a foreign direct investment license with the Indonesian government which permits it to build, own, and operate a crude oil refinery at the KIPI Maloy port and industrial park, a special economic zone located in the Kutai Timur Regency of East Kalimantan Province, Indonesia. The planned 24,000 barrels per day capacity Maloy Refinery is intended to produce motor fuels for local sale direct to underserved industrial and retail consumers within the East Kalimantan Province. The Company owns an 80% shareholding in KKC, and the Company's 85% owned Indonesian subsidiary, PT Continental Hilir Indonesia, owns the remaining 20%.
About PT MIT IVEL Geoscience - MIT is a privately owned contractor who specializes in site investigation services, geophysical surveys, and feasibility studies. MIT provides services to the oil and gas and mining industries throughout Indonesia.
On behalf of the Company,
Byron Tsokas
Vice President of Business Development
Source: Continental Energy Corporation
Media Contact: Byron Tsokas, Vice President, (1-403-629-8840) [email protected]
Further Information is posted on the Company's website at: www.continentalenergy.com
No securities regulatory authority has either approved or disapproved the contents of this news release.
Forward Looking Statements - Any statements in this news release that are not historical or factual at the date of this release are forward looking statements. There are many factors which may cause actual performance and results to be substantially different from any of the Company's plans, intentions, or objectives or similar forward looking statements described herein. In this release, there are no assurances that the geotechnical services contract will result in the successful realization of the planned refinery by the Company's subsidiary. Readers should also refer to the risk disclosures outlined in the Company's regulatory disclosure documents filed with the US SEC available at www.sec.gov. The Company assumes no obligation to update the information in this release.


Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Jetstar to Charge for Overhead Cabin Bags From February
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 



